CERVICAL CARCINOMA
Clinical trials for CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Edited immune cells take on Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a new treatment called CTX131 for adults with several types of advanced solid tumors that had stopped responding to standard therapies. CTX131 uses a patient's own immune cells that are edited with CRISPR technology to target a protein called CD70 on…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
At-Home HPV test could save lives in underscreened appalachia
Prevention CompletedThis study tested whether mailing HPV self-test kits to women in Appalachia who are behind on screening could increase cervical cancer detection. Over 800 women who hadn't had a Pap test in 3+ years or an HPV test in 5+ years took part. The goal was to see if self-testing at home…
Matched conditions: CERVICAL CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Prevention
Last updated May 15, 2026 11:57 UTC
-
Can a depression drug rekindle desire in cancer survivors?
Symptom relief CompletedThis study tested whether bupropion, a medication often used for depression, can improve low sexual desire in women who have had breast or gynecologic cancer. About 230 women took either bupropion or a placebo pill for 9 weeks. The goal was to see if the drug could safely boost d…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 17, 2026 03:10 UTC